8-K filing — TRICO BANCSHARES / (TCBK)
Filed: 2026-08-21 AccNo: 0000356171-26-000111 Size: 236 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Raymond James Downgrades TriCo Bancshares to Market Perform
Raymond James analyst David Feaster downgrades TriCo Bancshares (NASDAQ:TCBK) from Outperform to Market Perform.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK)
Law firm Brodsky & Smith announced investigations into four major merger transactions, examining whether the boards of MarketAxess Holdings, CBIZ, Sanara MedTech, and TriCo Bancshares breached fiduciary duties by failing to conduct fair processes and potentially underpaying shareholders. The firm is seeking shareholders to discuss potential class action lawsuits.
Piper Sandler Maintains Neutral on TriCo Bancshares, Raises Price Target to $63
Piper Sandler analyst Matthew Clark maintains TriCo Bancshares (NASDAQ:TCBK) with a Neutral and raises the price target from $61 to $63.
DA Davidson Maintains Neutral on TriCo Bancshares, Lowers Price Target to $65
DA Davidson analyst Jeff Rulis maintains TriCo Bancshares (NASDAQ:TCBK) with a Neutral and lowers the price target from $66 to $65.